Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jazz Pharma Plc (NQ: JAZZ )

106.09 +2.76 (+2.67%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 499,092
Open 103.46
Bid (Size) 99.00 (1)
Ask (Size) 107.20 (1)
Prev. Close 103.33
Today's Range 103.12 - 106.12
52wk Range 99.06 - 146.70
Shares Outstanding 62,311,104
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
How Is The Market Feeling About Jazz Pharmaceuticals?
Via Benzinga
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical... 
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
-16.42%
-16.42%
1 Month
-7.37%
-7.37%
3 Month
-2.58%
-2.58%
6 Month
-10.95%
-10.95%
1 Year
-15.92%
-15.92%

More News

Read More
Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Mid-Cap Growth Rockets Trading at Deep Discounts to Their Potential
Via InvestorPlace
Assessing Jazz Pharmaceuticals: Insights From 7 Financial Analysts
Via Benzinga
Decoding 12 Analyst Evaluations For Jazz Pharmaceuticals
Via Benzinga
Demystifying Jazz Pharmaceuticals: Insights From 15 Analyst Reviews
Via Benzinga
7 Biotech Stocks to Boost Your Portfolio to Peak Health
Via InvestorPlace
3 Cannabis Stocks That Could Make Your Grandchildren Rich
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Why Is Jazz Pharmaceuticals Stock Trading Lower On Thursday?
Via Benzinga
Jazz Dives — And Takes Praxis With It — On Essential Tremor Drug Failure
Via Investor's Business Daily
3 Blue-Chip Stocks to Triple Your Wealth by 2026: June Edition
Via InvestorPlace
Breaking Down Jazz Pharmaceuticals: 15 Analysts Share Their Views
Via Benzinga
This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
7 Overlooked Stocks Offering Long-Term Stability From the Shadows
Via InvestorPlace
3 Cannabis Stocks to Buy Now: May 2024
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
7 Blue-Chip Stocks to Buy Now: May 2024
Via InvestorPlace
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Cheap Blue-Chip Stocks to Buy Now: May 2024
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Via Benzinga
Topics Cannabis
Exposures Cannabis
7 Cannabis Stocks to Buy for a Smoking-Hot 2024
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
JAZZ Stock Earnings: Jazz Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
3 No-Brainer Stocks to Buy With $300 Right Now
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.